164 related articles for article (PubMed ID: 31192127)
41. Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma.
Shang C; Ao CN; Cheong CC; Meng L
Front Oncol; 2019; 9():27. PubMed ID: 30761271
[TBL] [Abstract][Full Text] [Related]
42. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
[TBL] [Abstract][Full Text] [Related]
43. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
44. Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis.
Saiprasad G; Chitra P; Manikandan R; Sudhandiran G
Eur J Cancer; 2014 Sep; 50(14):2489-507. PubMed ID: 25047426
[TBL] [Abstract][Full Text] [Related]
45. Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.
Guo F; Zhang H; Jia Z; Cui M; Tian J
Am J Cancer Res; 2018; 8(7):1317-1331. PubMed ID: 30094104
[TBL] [Abstract][Full Text] [Related]
46. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
47. Dysregulation of Krüppel-like factor 12 in the development of endometrial cancer.
Ding L; Ding Y; Kong X; Wu J; Fu J; Yan G; Zhou H
Gynecol Oncol; 2019 Jan; 152(1):177-184. PubMed ID: 30482501
[TBL] [Abstract][Full Text] [Related]
48. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of CYFIP2 promotes gastric cancer cell proliferation and chemoresistance to 5-fluorouracil through activation of the Akt signaling pathway.
Jiao S; Li N; Cai S; Guo H; Wen Y
Oncol Lett; 2017 Apr; 13(4):2133-2140. PubMed ID: 28454373
[TBL] [Abstract][Full Text] [Related]
50. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD
Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907
[TBL] [Abstract][Full Text] [Related]
51. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.
Hu JL; Hu XL; Guo AY; Wang CJ; Wen YY; Cang SD
Oncotarget; 2017 Jul; 8(30):49380-49394. PubMed ID: 28537902
[TBL] [Abstract][Full Text] [Related]
52. Expression of CDK9 in endometrial cancer tissues and its effect on the proliferation of HEC-1B.
Yang W; Liu S; Luo Q; Tan X
Open Life Sci; 2021; 16(1):1341-1346. PubMed ID: 35071768
[TBL] [Abstract][Full Text] [Related]
53. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
Xia A; Li H; Li R; Lu L; Wu X
Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
[TBL] [Abstract][Full Text] [Related]
54. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
55. Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells.
Block M; Fister S; Emons G; Seeber S; Gründker C; Günthert AR
Anticancer Res; 2010 Jun; 30(6):2025-31. PubMed ID: 20651347
[TBL] [Abstract][Full Text] [Related]
56. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
57. MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.
Ran X; Yang J; Liu C; Zhou P; Xiao L; Zhang K
Int J Clin Exp Pathol; 2015; 8(6):6617-26. PubMed ID: 26261543
[TBL] [Abstract][Full Text] [Related]
58. Determinants of rapamycin sensitivity in breast cancer cells.
Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
[TBL] [Abstract][Full Text] [Related]
59. Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B.
Liu P; Qi M; Ma C; Lao G; Liu Y; Liu Y; Liu Y
FEBS Lett; 2013 Aug; 587(16):2523-9. PubMed ID: 23769985
[TBL] [Abstract][Full Text] [Related]
60. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
